Additionally, GLP-1 slows gastric emptying, meaning food stays in your stomach longer, enhancing feelings of fullness and allowing you to comfortably reduce portion sizes and frequency of meals
Conversely, low-dose GLP-1 therapy is not appropriate for patients without established indications, particularly those seeking anti-inflammatory effects alone without diabetes or obesity
Tight glycemic control, blood pressure optimization, lipid management, smoking cessation, and routine foot exams remain critical
Why Ignoring Appetite Hormones Can Be Risky Uncontrolled appetite does not just affect weight
INTRODUCTION The recent and rapid rise of the GLP-1 receptor agonists semaglutide (Ozempic, Rybelsus and Wegovy) and tirzepatide (Mounjaro and Zepbound) offers a critical lens through which we can examine the intersection of financialization, patent abuse, and health inequities in the pharmaceutical industry
Want to book a telehealth doctor appointment to get the best GLP-1 for weight loss